NuVasive Launches Reline Cervical for Posterior Cervical Fusion as Part of the C360 Portfolio

The cervical solution marks the completion of the NuVasive Reline fixation portfolio for complex deformity from occiput to sacrum SAN DIEGO, Sept. 28, 2022 /PRNewswire/ — NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with…

Click here to view original post